Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.44 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.41 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | PORCN | Q9H237 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | F10 | P00742 | 2/20 | 0.39 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10312981 | 0.79 | NOTUM (0.42) | HRH3NOTUMKMT2AHSP90AA1HSP90B1 | |
| SCHEMBL10312979 | 0.78 | HRH3 (0.67) | HRH3NOTUMALDH1A1KMT2ANPC1 | |
| SCHEMBL10312983 | 0.78 | NOTUM (0.41) | HRH3NOTUMKMT2AHSP90AA1HSP90B1 | |
| SCHEMBL16592794 | 0.78 | NOTUM (0.46) | NOTUMHSP90AA1ENPP2 | |
| SCHEMBL5386833 | 0.78 | NOTUM (0.46) | HRH3NOTUMHSP90AA1ENPP2CREBBP | |
| SCHEMBL15926459 | 0.75 | SMN1; SMN2 (0.44) | ALDH1A1KMT2AHSP90AA1HSP90B1RAB9A | |
| SCHEMBL5470665 | 0.74 | BAZ2B (0.45) | NOTUMALDH1A1KMT2ANPC1RAB9A | |
| SCHEMBL14135312 | 0.73 | DHFR (0.41) | ALDH1A1HSP90AA1HSP90B1RAB9AMAPT | |
| SCHEMBL15309449 | 0.73 | ABHD6 (0.49) | ALDH1A1HSP90AA1 | |
| SCHEMBL13226354 | 0.72 | MAPT (0.48) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120178776-A1 | DIHYDRONAPHTHYRIDINYL(ORGANO)METHANONE ANALOGS AS POSITIVE ALLOSTERIC MGLUR5 MODULATORS | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2012-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178776-A1 | DIHYDRONAPHTHYRIDINYL(ORGANO)METHANONE ANALOGS AS POSITIVE ALLOSTERIC MGLUR5 MODULATORS | GRM5, GRIK5, GRM3 | HRH3 350/4885NOTUM 2863/4885ALDH1A1 4339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.